CRON - Esperion Therapeutics Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session | Benzinga
U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday.
Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) rose sharply in today’s pre-market trading.
The U.S. FDA approved broad new labels for Esperion's NEXLETOL® and NEXLIZET® to prevent heart attacks and cardiovascular procedures in both primary and secondary prevention patients, regardless of statin use.
Esperion Therapeutics shares jumped 12.7% to $2.58 in pre-market trading.
Here are some big stocks recording gains in today’s pre-market trading session.
- Forge Global Holdings, Inc. (NYSE: FRGE) shares gained 22.8% to $2.86 in pre-market trading ...